BCYC
Bicycle Therapeutics
$3.65
+$0.10 (+2.82%)Oct 26, 2026
Key metrics
The numbers that frame BCYC today
- Market cap
- $255.47M
- Gross margin
- 100%
- ROIC
- -351.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.33
- 52wk High
- $9.08
Growth
Revenue and earnings trend for BCYC
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BCYC
Is Bicycle Therapeutics a good buy?
No. Bicycle Therapeutics has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of BCYC?
Bicycle Therapeutics's market capitalization is $255.47M.
What is the 52-week high for BCYC stock?
The 52-week high for Bicycle Therapeutics is $9.08. The current close of $3.65 is 59.8% below that high.
What is the 52-week low for BCYC stock?
The 52-week low for Bicycle Therapeutics is $3.33. The current close of $3.65 is 9.6% above that low.
Does BCYC stock pay dividends?
Bicycle Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BCYC?
Bicycle Therapeutics's Debt / Equity ratio is 0.03.